Celebrex Ad Takes Aim At OTCs, Other Rx Analgesics
This article was originally published in The Tan Sheet
Executive Summary
Pfizer's new Celebrex ad campaign is the latest example of the ongoing marketing battle between COX-2s and OTC medications for reducing joint pain
You may also be interested in...
FDA Drug Safety Process Subject To IoM Review Under Agency Initiative
FDA will sponsor an Institute of Medicine study of the agency's drug safety process as part of a broad initiative to strengthen the pre- and post-market evaluation of drugs
Wyeth, McNeil Strike Swiftly With Ads After Vioxx Recall
Wyeth Consumer Health and McNeil are capitalizing on concerns generated by Merck's recall of its prescription pain reliever Vioxx with ads for Advil (ibuprofen) and Tylenol (acetaminophen)
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC